That's why the CDC website says Covid (leaky, non-sterilizing) vaccines only provide protection (in blood) against serious illness, not infection (in nose). A future nasal vaccine may provide sterilizing immunity (what most people assume they are getting from a "vaccine", like their personal experience with the MMR vaccine).
What? No, there isn't. The Covid vaccines we have today are not sterilizing. Period. This isn't a conspiracy theory or anything like that, it's just a simple fact.
BBC article on immunity, https://www.bbc.com/news/health-58270098
> There is a whole different suite of antibodies (known as immunoglobulin As) in the nose and lungs, compared with those (immunoglobulin Gs) that we measure in the blood. The former is more important as a barrier to infection. Natural infection, because it is in the nose rather than a jab in the arm, may be a better route to those antibodies, and nasal vaccines are being investigated too.
Intramuscular (arm injection) vs intranasal (inhaled) vaccines: https://news.ycombinator.com/item?id=28165287
Nasal vaccine trials: https://news.ycombinator.com/item?id=28284504
This is conjecture. It's a hypothetical effect to take into consideration, but it's certainly not borne out in data that the vaccines increase asymptomatic transmission, much less for this reason.
> Based on evolving evidence, CDC recommends fully vaccinated people get tested 5-7 days after close contact with a person with suspected or confirmed COVID-19.
For many people, this description could apply to daily activity, e.g. riding on public transit. So the CDC is recommended regular testing of vaccinated people. Since the vaccine can suppress symptoms, testing can be used to detect infection earlier, enabling isolation and/or treatments which only work early in the progression of Covid.
In a July 2021 paper from academics advising UK SAGE, https://www.gov.uk/government/publications/long-term-evoluti...
> Whilst we feel that current vaccines are excellent for reducing the risk of hospital admission and disease, we propose that research be focused on vaccines that also induce high and durable levels of mucosal immunity in order to reduce infection of and transmission from vaccinated individuals. This could also reduce the possibility of variant selection in vaccinated individuals.
Note the reference to transmission from vaccinated individuals. There was also a study of Vietnamese healthcare workers, showing that 70% of infections were pre-symptomatic, https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3897733
> 69 healthcare workers were tested positive for SARS-CoV-2. 62 participated in the clinical study. 49 were (pre)symptomatic ... Breakthrough Delta variant infections are associated with high viral loads, prolonged PCR positivity, and low levels of vaccine-induced neutralizing antibodies, explaining the transmission between the vaccinated people. Physical distancing measures remain critical to reduce SARS-CoV-2 Delta variant transmission.
If 2021 consumer media is offering variable definitions, Cui Bono?